Intuitive surgical EVP Gary Loeb sells $151,600 in common stock
Intuitive Surgical's Executive Vice President and Chief Legal and Compliance Officer, Gary Loeb, divested 400 shares of the company's stock on August 10, 2026, amassing a total of $151,600 from the sale. The shares were traded at a rate of $379.00 each. Since the transaction, the stock's price has surged to $393.38, trading below its InvestingPro Fair Value, potentially indicating an undervaluation.
Intuitive Surgical's market value stands at $138.97 billion, accompanied by a robust gross profit margin of 66.68%. Following the sale, Loeb currently possesses 5,320 shares of the company's stock. This transaction was executed under a pre-established trading plan, referred to as a Rule 10b5-1 plan, which is set to conclude on January 29, 2027.
Intuitive Surgical recently disclosed second-quarter results that surpassed analysts' predictions. The company reported earnings per share of $2.80, surpassing the projected $2.51, and revenue grew 19% to $2.89 billion, outperforming the estimated $2.82 billion. The company's instruments and accessories sales surged by 18% to $1.73 billion, while systems sales increased by 19% to $685 million, with the delivery of 468 da Vinci systems.
Despite these impressive figures, concerns arose among investors due to Intuitive Surgical's projected full-year procedure growth. UBS initiated coverage of the company with a buy rating and a price target of $500, underscoring the firm's prominence in the medical technology sector. Conversely, Bernstein revised its price target from $750 to $685, preserving an Outperform rating, citing U.S. growth apprehensions.
BMO Capital maintained an Outperform rating with a $518 price target following the earnings beat. Stifel reduced its price target to $550 from $670, still holding a Buy rating, due to uncertainty surrounding management's statements. These diverse analyst viewpoints highlight the complexity of Intuitive Surgical's future growth prospects. This report was assisted by AI technology and revised by an editor.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
